About Gene2Go
Gene2Go is a company based in Chennai (India) founded in 2023 by AJ Rastogi and Yajamana Ramu. Gene2Go offers products and services including Plant Genomics, Customized Plasmids, Recombinant Proteins, CRISPR Diagnostic Kits, and RNA-based Nano Spray. Gene2Go operates in a competitive market with competitors including Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.
- Headquarter Chennai, India
- Founders AJ Rastogi, Yajamana Ramu
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gene2go Pvt Ltd
- Jurisdiction Chennai City Corporation, Tamil Nadu, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gene2Go
Gene2Go offers a comprehensive portfolio of products and services, including Plant Genomics, Customized Plasmids, Recombinant Proteins, CRISPR Diagnostic Kits, and RNA-based Nano Spray.
CRISPR solutions for gene editing in various plant species.
Custom vectors for research using advanced cloning techniques.
High-quality proteins tailored for research applications.
Kits for plant pathogen detection using CRISPR technology.
Spray for managing plant diseases through RNA nanotechnology.
Funding Insights of Gene2Go
Detailed funding history for Gene2Go
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gene2Go
Investment portfolio details for Gene2Go
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gene2Go
Detailed financials for Gene2Go
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gene2go Comparisons
Peer comparison for Gene2Go
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gene2Go
Gene2Go operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beam Therapeutics, eGenesis, Korro Bio, Metagenomi and Prime Medicine, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| Locked | Locked | Locked |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| Locked | Locked | Locked |
Genetic therapies for diseases are developed using prime editing technology.
|
|
| Locked | Locked | Locked |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
Detailed competitors of Gene2Go
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gene2go
Complete news archive for Gene2Go
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gene2Go
Gene2Go was founded in 2023.
Gene2Go is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
Gene2Go was founded in 2023 in Chennai, India, within the bioinformatics and genomics sector. CRISPR technology is utilized for genome editing services, with emphasis placed on gene ontology analysis and enrichment. Tools and resources are supplied to researchers for genomic data interpretation, including gene set and pathway enrichment studies. Insights into potential therapeutic targets are facilitated through these offerings.
Gene2Go's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
Gene2Go offers Plant Genomics, Customized Plasmids, Recombinant Proteins, CRISPR Diagnostic Kits, and RNA-based Nano Spray.